Cell Mol Neurobiol 41(7):13951411 Wang R, Wu Y, Liu R, Liu M, Li Q, Ba Y, Huang H (2022) Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study
In terms of efficacy, DexL and DexN did not differ significantly ( p = 0.32)
Deg-AZM reached peak distribution at 0.167 h in the liver, stomach, intestine, and ovaries after administration, at 3 h in testes, and at 0.5 h in other tissues
Food and Drug Administration (FDA) has given it "Generally Recognized as Safe" (GRAS) status for use in food products